Astrana Health Inc. reports developments in physician-centric, technology-enabled healthcare management, including its care delivery infrastructure, proprietary technology platform, and aligned provider networks. The company describes a payer-agnostic, risk-bearing care model designed around coordinated, preventive care and population health management.
Recurring news themes include quarterly and annual financial results, medical cost performance, full-risk contract activity, integration of completed acquisitions, investor-conference presentations, and updates involving governance, capital structure, and operating performance. Company materials also discuss its Care Partners, Care Delivery, and Care Enablement segments.
Astrana Health (NASDAQ: ASTH) reported strong Q2 2025 financial results, with total revenue reaching $654.8 million, up 35% year-over-year, and adjusted EBITDA of $48.1 million. The company's Care Partners segment led growth with revenue of $631.4 million, a 36% increase.
Key highlights include the completion of the Prospect Health acquisition for $707.9 million on July 1, 2025, financed through a five-year delayed draw term loan. The company also strengthened its leadership team with several strategic appointments, including Sherry McBride as COO.
Astrana reiterated its full-year 2025 guidance, projecting total revenue between $3.1-3.3 billion and adjusted EBITDA of $215-225 million, which includes the Prospect Health acquisition impact.
Astrana Health (NASDAQ: ASTH), a provider-centric healthcare technology company, has scheduled its Q2 2025 financial results announcement for Thursday, August 7, 2025, after market close.
The company will host a conference call at 2:30 PM PT/5:30 PM ET on the same day to discuss the results. Participants can join via phone (877-858-9810 or +1 201-689-8517) or webcast. A slide presentation will be available on the company's IR website, and a recording will be accessible after the call.
Astrana Health (NASDAQ: ASTH) has completed the acquisition of Prospect Health for $708 million, down from the initially announced $745 million. Prospect Health is a value-based care network with 11,000+ providers serving approximately 600,000 members across multiple states.
The acquisition is expected to contribute $1.2 billion in revenue and $81 million in adjusted EBITDA annually, with anticipated synergies of $12-15 million over the next 12-18 months. Astrana has updated its 2025 guidance to $3.1-3.3 billion in total revenue and $215-225 million in adjusted EBITDA.
Post-acquisition, Astrana will have $700 million in net debt and aims to reduce its net leverage ratio to below 2.5x within 12-18 months.
Astrana Health (NASDAQ: ASTH) reported strong Q1 2025 financial results, with total revenue reaching $620.4 million, up 53% year-over-year. Care Partners revenue increased 57% to $601.0 million. However, net income decreased to $6.7 million from $14.8 million, with diluted EPS of $0.14 compared to $0.31 in Q1 2024.
The company announced key leadership additions, including Georgie Sam as Chief Data & Analytics Officer and Glenn Sobotka as Chief Accounting Officer. Astrana successfully integrated Collaborative Health Systems and received HSR approval for its pending Prospect Health acquisition. For Q2 2025, the company expects revenue between $615-655 million and adjusted EBITDA of $45-50 million. Full-year 2025 guidance projects revenue of $2.5-2.7 billion and adjusted EBITDA of $170-190 million.
Astrana Health (NASDAQ: ASTH), a provider-centric, technology-powered healthcare company, has announced its participation in the upcoming BofA Securities 2025 Health Care Conference in Las Vegas. The company's leadership, including President and CEO Brandon Sim and CFO/COO Chan Basho, will engage in a fireside chat scheduled for May 13, 2025, at 3:00 PM PT.
Investors and interested parties can access the webcast through the IR Calendar section on Astrana Health's investor relations website at ir.astranahealth.com/news-events/ir-calendar.
Astrana Health (NASDAQ: ASTH) has announced it will release its financial results for Q1 2025 (ending March 31, 2025) after market close on Thursday, May 8, 2025. The company will host a conference call to discuss the results at 2:30 p.m. PT/5:30 p.m. ET on the same day.
Participants can join the call using dial-in numbers (877) 858-9810 (domestic) or +1 (201) 689-8517 (international). A PDF slide presentation will be available on the company's IR Calendar webpage. The event will also be accessible via webcast, with a recording available shortly after the call's conclusion.
Astrana Health (NASDAQ: ASTH) reported its Q4 and full-year 2024 financial results, demonstrating significant growth. For FY2024, total revenue reached $2,034.5 million, up 47% year-over-year, with Care Partners revenue increasing 52% to $1,949.0 million. However, net income decreased to $43.1 million from $60.7 million in 2023.
Q4 2024 showed mixed results with total revenue up 88% to $665.2 million, but recorded a net loss of $7.0 million compared to income of $12.4 million in Q4 2023. The company secured a new credit agreement with Truist Bank, providing access to $300 million revolving credit, $250 million term loan, and $745 million delayed draw term loan facilities.
Recent highlights include a new Care Enablement partnership with Provider HealthLink in Georgia, expected to serve 10,000 Medicare Advantage members. Additionally, eight Astrana affiliates achieved Elite status in APG's 2024 Standards of Excellence survey.
Astrana Health (NASDAQ: ASTH), a provider-centric healthcare technology company, has announced its participation in five major investor conferences in March 2025. President and CEO Brandon Sim will represent the company at:
- TD Cowen 45th Annual Health Care Conference in Boston (March 3)
- Jefferies Value-Based Healthcare Summit in Miami (March 10)
- Barclays 27th Annual Global Healthcare Conference in Miami (March 11)
- Oppenheimer 35th Annual Healthcare Conference (Virtual, March 17)
- KeyBanc Capital Markets Healthcare Forum (Virtual, March 18)
At the Jefferies summit, Sim will participate in panel discussions on Value-Based Policy and Technology/AI in VBC, along with a fireside chat. The other conferences will feature presentations and fireside chats, with webcasts available through the company's IR Calendar webpage.